Viridian Therapeutics
VRDN
#5423
Rank
โ‚น83.51 B
Marketcap
โ‚น1,025
Share price
-5.22%
Change (1 day)
-24.77%
Change (1 year)

Revenue for Viridian Therapeutics (VRDN)

Revenue in 2024 (TTM): โ‚น25.38 Million

According to Viridian Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น25.81 Million. a decrease over the revenue in the year 2023 that were of โ‚น26.14 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Viridian Therapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น25.9 M-0.89%
2023 โ‚น26.14 M-82.17%
2022 โ‚น0.14 B-33.51%
2021 โ‚น0.22 B187.2%
2020 โ‚น76.79 M-75.86%
2019 โ‚น0.31 B-45.75%
2018 โ‚น0.58 B129.41%
2017 โ‚น0.25 B12.71%
2016 โ‚น0.22 B34.4%
2015 โ‚น0.16 B-38.38%
2014 โ‚น0.27 B2.68%
2013 โ‚น0.26 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA